title: [Development of anti-influenza drug].
authors: Tao
authors: T
authors: Zhang
authors: Cheng-Yu
authors: CY
authors: Wang
authors: Yu-Wei
authors: YW
authors: Gao
authors: Song-Tao
authors: ST
authors: Yang
authors: Tie-Cheng
authors: TC
authors: Wang
authors: Xian-Zhu
authors: XZ
authors: Xia
mesh_terms: D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors; D055808:Drug Discovery; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000737:chemistry / Q000378:metabolism; D006801:Humans; D009980:Influenza A virus / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D007251:Influenza, Human / Q000188:drug therapy*; D058990:Molecular Targeted Therapy; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D019590:Nucleocapsid Proteins; D016601:RNA-Binding Proteins / Q000037:antagonists & inhibitors; D015398:Signal Transduction / Q000187:drug effects; D014758:Viral Core Proteins / Q000037:antagonists & inhibitors; D014763:Viral Matrix Proteins / Q000037:antagonists & inhibitors; D000086082:Viroporin Proteins
chemical_list: D000998:Antiviral Agents; D012321:DNA-Directed RNA Polymerases; D019267:Hemagglutinin Glycoproteins, Influenza Virus; D009439:Neuraminidase; D019590:Nucleocapsid Proteins; D016601:RNA-Binding Proteins; D014758:Viral Core Proteins; D014763:Viral Matrix Proteins; C488937:M2 protein, Influenza A virus; D000086082:Viroporin Proteins; C048842:NP protein, Influenza A virus